Recent data reveals that chronic absenteeism in schools has reached unprecedented levels post-COVID-19, creating what experts are calling the ‘new normal’. The pandemic dramatically disrupted educational settings, leading to a drastic increase in absentee rates as both students and educators grapple with new challenges in a post-COVID landscape. Education systems are now confronting this issue head-on as they implement strategies to mitigate these rising numbers. With many families still recovering from the socio-economic impacts of COVID-19, chronic absenteeism has been further exacerbated by issues like mental health struggles, lack of access to reliable transportation, and the remnants of online learning fatigue. Schools across the nation are urged to adopt adaptable, inclusive policies to address the complex needs of their students. This situation highlights a critical area of concern for policymakers who are striving to ensure that every child receives a consistent education, emphasizing the importance of attendance as a cornerstone of student success.
YahooNew data shows CLYM116 reduces key IgA nephropathy biomarkers by ~70%, supporting a 12-week dosing regimen
New data released by CLIMB Bio and MabWorks reveals that their investigational drug CLYM116 significantly reduces critical biomarkers associated with IgA nephropathy by approximately 70%.